MedPath

Rt-PA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke

Not Applicable
Completed
Conditions
Ischemic Stroke
Interventions
Device: Remote ischemic conditioning
Registration Number
NCT03231384
Lead Sponsor
Capital Medical University
Brief Summary

The purpose of this study is to determine the safety and feasibility of remote limb ischemic conditioning(RIC) in acute ischemic stroke patients who received r-tPA thrombolytic therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • Male or female, age≥18;
  • Acute ischemic stroke;
  • modified Rankin Scale (mRS) score of 2-5;
  • mRS score less than 1 before onset of stroke symptom;
  • Onset of stroke symptoms within 4.5h before initiation of intravenous rt-PA thrombolytic therapy;
  • Good compliance for Remote Ischemic Conditioning(RIC) therapy;
  • Informed consent obtained.
Exclusion Criteria
  • Stroke or serious head trauma within the previous 3 months
  • Major surgery or severe trauma with in the preceding 3 months
  • Intracranial hemorrhage
  • Systolic pressure greater than 185 mm Hg or diastolic pressure greater than 110 mm Hg, or aggressive treatment intravenous medication) necessary to reduce blood pressure to these limits
  • Symptoms rapidly improving
  • Symptoms suggestive of subarachnoid hemorrhage, even if CT scan was normal
  • Gastrointestinal hemorrhage or urinary tract hemorrhage within the previous 21 days
  • Arterial puncture at a noncompressible site within the previous 7 days
  • Seizure at the onset of stroke
  • Platelet count of less than 100,000 per cubic millimeter
  • Received heparin within the 48 hours preceding the onset of stroke and had an elevated partial-thromboplastin time
  • Received oral anticoagulation therapy preceding the onset of stroke and INR greater than 1.7 or prothrombin times greater than 15 seconds
  • CT showed a multiple infarction (low density area greater than 1/3 cerebral hemisphere)
  • Use or plan to use intervention for diagnosis or treating
  • Intracranial neoplasm, cerebral aneurysm or arteriovenous malformation
  • severe hepatic or renal dysfunction
  • Contraindication for remote ischemic conditioning: severe soft tissue injury, fracture, or peripheral vascular disease in the upper limbs.
  • Life expectancy<1 years
  • Pregnant or breast-feeding women
  • Unwilling to be followed up or poor compliance for treatment
  • Patients being enrolled or having been enrolled

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RIC groupRemote ischemic conditioningThe upper limb ischemic conditioning is composed of five cycles of upper limb ischemia intervened by reperfusion, which is induced by two cuff placed around the upper arms respectively and inflated to 200 mm Hg for 5 minutes followed by 5 minutes of reperfusion by cuff deflation. This therapy started within 2 hours after r-tPA thrombolytic therapy. In addition, all participants receive a standard clinical therapy.
Primary Outcome Measures
NameTimeMethod
Feasibility of RIC after acute ischemic stroke7 days

The proportion of enrolled subjects that completed all the designed RIC procedures.

Secondary Outcome Measures
NameTimeMethod
Objective signs of tissue or neurovascular injurywithin 7(±24h) days

objective signs of tissue or neurovascular injury felt to be due to cuff inflation. Inspection included palpation of distal radial pulses, visual inspection (for local edema, redness, skin breakdown), and palpation for tenderness

Number of participants with intracranial hemorrhage in two groups7(±24h)days
Scores assessed by National Institutes of Health Stroke Scale(NIHSS)7(±24h)days
The functional outcome at 90 days assessed by modified Rankin scale (mRS).90( ±7days) days
functional outcome assessed by Barthel Index(BI)90( ±7days)days
cerebral infarct volume.3-7 days after stroke onset

The infarct volume of cerebral infarct is evaluated by cranial noncontrast CT

Cardiovascular parameters during 7 days of RIC treatment.7 days

the blood pressure were measured immediately before RIC and also be measured 5 minutes after RIC.

the heart rate during 7 days of RIC treatment.7 days

the heart rate were measured immediately before RIC and also be measured 5 minutes after RIC.

Levels of plasma myoglobinbaseline and 7(±2)days
Levels of serum IL-6baseline and 7(±2)days
Levels of serum HS-CRPbaseline and 7(±2)days
Levels of serum HCYbaseline and 7(±2)days
Any adverse events90(±7)days

Trial Locations

Locations (1)

Xuanwu Hospital, Capital Medical University

🇨🇳

Beijing, XI Cheng District, China

© Copyright 2025. All Rights Reserved by MedPath